0001209191-18-022186.txt : 20180330 0001209191-18-022186.hdr.sgml : 20180330 20180330141452 ACCESSION NUMBER: 0001209191-18-022186 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180329 FILED AS OF DATE: 20180330 DATE AS OF CHANGE: 20180330 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GOLD DANIEL P PHD CENTRAL INDEX KEY: 0001288233 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-50484 FILM NUMBER: 18725739 MAIL ADDRESS: STREET 1: 10445 PACIFIC CENTER CT CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MEI Pharma, Inc. CENTRAL INDEX KEY: 0001262104 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 510407811 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 3611 VALLEY CENTER DRIVE STREET 2: SUITE 500 CITY: SAN DIEGO STATE: CA ZIP: 92130 BUSINESS PHONE: 858-792-6300 MAIL ADDRESS: STREET 1: 3611 VALLEY CENTER DRIVE STREET 2: SUITE 500 CITY: SAN DIEGO STATE: CA ZIP: 92130 FORMER COMPANY: FORMER CONFORMED NAME: MARSHALL EDWARDS INC DATE OF NAME CHANGE: 20030902 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-03-29 0 0001262104 MEI Pharma, Inc. MEIP 0001288233 GOLD DANIEL P PHD C/O MEI PHARMA, INC. 3611 VALLEY CENTRE DRIVE, SUITE 500 SAN DIEGO CA 92130 1 1 0 0 Chief Executive Officer Common Stock 2018-03-29 4 F 0 128920 2.07 D 271080 D Represents the number of shares withheld by and surrendered to the Issuer on March 29, 2018, to satisfy tax withholding obligations that arose in connection with the delivery of shares underlying vested restricted stock units. /s/ Brian G. Drazba, as attorney-in-fact 2018-03-30